SMAD3 and inflammatory bowel disease: Since Smad3 differentially regulates the induction of regulatory and inflammatory Th17 cell differentiation [53], which are key players in the IBD pathogenesis [54], further investigations analyzing Th17 cell differentiation in IBD patients carrying CEACAM6 variants might also be of high interest.